Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123676462 | 12367646 | 2 | F | 20160525 | 20160513 | 20160725 | PER | US-JNJFOC-20160326595 | JANSSEN | 0.00 | A | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123676462 | 12367646 | 1 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | N | UNKNOWN | 19835 | TABLET | ||||||||
| 123676462 | 12367646 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 1/2 OF A TABLET, EVERY DAY FOR TWO WEEKS | N | UNKNOWN | 19835 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123676462 | 12367646 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123676462 | 12367646 | Incorrect dose administered | |
| 123676462 | 12367646 | Multiple allergies | |
| 123676462 | 12367646 | Oral pruritus | |
| 123676462 | 12367646 | Pruritus | |
| 123676462 | 12367646 | Therapeutic response decreased | |
| 123676462 | 12367646 | Urticaria | |
| 123676462 | 12367646 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |